Stroke in children with sickle cell disease (original) (raw)

• Earley CJ, Kittner SJ, Feeser BR, et al.: Stroke in children and sickle-cell disease. Neurology 1998, 51:169–176.
  PubMed CAS Google Scholar
• Scothorn DJ, Price C, Schwartz D, et al.: Risk of recurrent stroke in children with sickle cell disease receiving blood transfusion therapy for at least five years after initial stroke. J Pediatr 2002, 140:348–354. In a multicenter study of patients receiving blood transfusion for at least 5 years after stroke, the recurrence rate was 2.2 per 100 patient years. None of the patients who had had their first stroke in the context of a medical event had a second stroke after 2 years. For the other patients who had had their first strokes without warning, the recurrence rate was 1.9 per 100 patient years. However, vascular imaging to confirm or exclude moyamoya was not available.
  Article PubMed Google Scholar
• Ohene-Frempong K, Weiner SJ, Sleeper LA, et al.: Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood 1998, 91:288–294. Ischemic stroke was more common children and older patients and the risk factors were previous transient ischemic attack, low haemoglobin, recent chest crisis, and hypertension. Intracranial hemorrhage occurred mainly in young adults and the risk factors were low haemoglobin and high leukocyte count.
  PubMed CAS Google Scholar
• Adams RJ, McKie VC, Carl EM, et al.: Long-term stroke risk in children with sickle cell disease screened with transcranial Doppler. Ann Neurol 1997, 42:699–704.
  Article PubMed CAS Google Scholar
• Adams RJ: Prevention of stroke by transfusion in sickle cell disease. N Engl J Med 1998, 339:5–11. This randomized controlled trial study of blood transfusion for patients with transcranial Doppler internal carotid or middle cerebral artery velocities greater than 200 cm per sec showed a 92% reduction in the risk of stroke in the treatment arm. However, 10 of 63 patients in the treatment arm dropped out mostly because of alloimmunization or poor compliance.
  Article PubMed CAS Google Scholar
• Fullerton HJ, Adams RJ, Zhao S, Johnston SC: Declining stroke rates in Californian children with sickle cell disease Blood, 2004 Mar 30 [Epub ahead of print]
• Adams RJ: Lessons from the Stroke Prevention Trial in Sickle Cell Anemia (STOP) study. J Child Neurol 2000, 15:344–349.
  Article PubMed CAS Google Scholar
• World Health Organization: Cerebrovascular disorders: a clinical and research classification. Geneva, Switzerland: World Health Organization; 1978 Offset Publication Number 43.
  Google Scholar
• Ganesan V, Prengler M, McShane MA, et al.: Investigation of risk factors in children with arterial ischemic stroke. Ann Neurol 2003, 53:167–173.
  Article PubMed Google Scholar
• Mercuri E, Faundez JC, Roberts I, et al.: Neurological ‘soft’ signs may identify children with sickle cell disease who are at risk for stroke. Eur J Pediatr 1995, 154:150–156.
  PubMed CAS Google Scholar
• Prengler M, Pavlakis SG, Boyd S, et al.: Increased cerebral blood flow velocities and risk of cerebral ischemia in sickle cell patients with seizures and those without seizures. Ann Neurol 2002, 52(Suppl):132–133.
  Google Scholar
• Kirkham FJ, Calamante F, Bynevelt M, et al.: Perfusion MR abnormalities in patients with sickle cell disease: relation to symptoms, infarction and cerebrovascular disease. Ann Neurol 2001, 49:477–485.
  Article PubMed CAS Google Scholar
• Huttenlocher PR, Moohr JW, Johns L, Brown FD: Cerebral blood flow in sickle cell cerebrovascular disease. Pediatrics 1984, 73:615–621.
  PubMed CAS Google Scholar
• Vichinsky EP, Neumayr LD, Earles AN, et al.: Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. N Engl J Med 2000, 22:342:1855–1865.
  Article Google Scholar
• Henderson JN, Noetzel MJ, McKinstry RC, et al.: Reversible posterior leukoencephalopathy syndrome and silent cerebral infarcts are associated with acute chest syndrome in sickle cell disease. Blood 2003, 101:415–9. This case series of patients with sickle cell disease who presented with neurologic events after acute chest syndrome showed that the pathologic spectrum is broader than in ischemic stroke in an arterial distribution.
  Article PubMed CAS Google Scholar
• Lee KH, McKie VC, Sekul EA, et al.: Unusual encephalopathy after acute chest syndrome: acute necrotizing encephalitis. J Pediatr Hematol Oncol 2002, 24:585–588.
  Article PubMed Google Scholar
• Wierenga KJ, Serjeant BE, Serjeant GR: Cerebrovascular complications and parvovirus infection in homozygous sickle cell disease. J Pediatr 2001, 139:438–442.
  Article PubMed CAS Google Scholar
• Kirkham FJ, Hewes DK, Hargrave D, et al.: Nocturnal hypoxaemia predicts CNS events in sickle cell disease. Lancet 2001, 357:1656–1659. Of a cohort of 95 patients with sickle cell disease who were screened prospectively with transcranial Doppler ultrasound and pulse oximetry, 19 had a CNS event during follow-up (six ischemic and one hemorrhagic stroke, eight transient ischemic attacks, and four seizures). Mean overnight oxygen saturation was an independent risk factor for predicting CNS events.
  Article PubMed CAS Google Scholar
• Lewin P, Goodell RA Jr: Post-operative blindness, with complete recovery, in a patient with sickle-cell anaemia. Br Med J 1962, 5316:1373.
  Google Scholar
• Siegel JF, Rich MA, Brock WA: Association of sickle cell disease, priapism, exchange transfusion and neurological events: ASPEN syndrome. J Urol 1993, 150:1480–1482.
  PubMed CAS Google Scholar
• Rackoff WR, Ohene-Frempong K, Month S, et al.: Neurologic events after partial exchange transfusion for priapism in sickle cell disease. J Pediatr 1992, 120:882–885.
  Article PubMed CAS Google Scholar
• Horton DP, Ferriero DM, Mentzer WC: Nontraumatic fat embolism syndrome in sickle cell anemia. Pediatr Neurol 1995, 12:77–80.
  Article PubMed CAS Google Scholar
• Coley SC, Porter DA, Calamante F, et al.: Quantitative MR diffusion mapping and cyclosporine-induced neurotoxicity. AJNR Am J Neuroradiol 1999, 20:1507–1510.
  PubMed CAS Google Scholar
• Gadian DG, Calamante F, Kirkham FJ, et al.: Diffusion and perfusion magnetic resonance imaging in childhood stroke. J Child Neurol 2000, 15:279–283.
  Article PubMed CAS Google Scholar
• van Mierlo TD, van den Berg HM, Nievelstein RAJ, Braun KPJ: An unconscious girl with sickle cell disease. Lancet 2003, 361:136. This is a well-documented study of straight, sigmoid, transverse and partial sagittal sinus thrombosis in a child with sickle cell disease who responded clinically to anticoagulation with heparin.
  Article PubMed Google Scholar
• Di Roio C, Jourdan C, Terrier A, Artru F: Sickle cell anemia and internal cerebral vein thrombosis. Ann Fr Anesth Reanim 1997, 16:967–969.
  PubMed Google Scholar
• O_uz M, Aksungur EH, Soyupak SK, Yildirim AU: Vein of Galen and sinus thrombosis with bilateral thalamic infarcts in sickle cell anaemia: CT follow-up and angiographic demonstration. Neuroradiology 1994, 36:155–156.
  Article Google Scholar
• Garcia JH: Thrombosis of cranial veins and sinuses: brain parenchymal effects. In Cerebral Sinus Thrombosis: Experimental and Clinical Aspects. Edited by Einhäupl K, Kempski O, Baethmann A New York: Plenum Press; 1990:27–37.
  Google Scholar
• Powars D, Adams RJ, Nichols FT, Milner P, Charache S, Sarnaik S: Delayed intracranial hemorrhage following cerebral infarction in sickle cell anemia. J Assoc Acad Minor Phys 1990, 1:79–82.
  PubMed CAS Google Scholar
• Balkaran B, Char G, Morris JS, et al.: Stroke in a cohort of patients with homozygous sickle cell disease. J Pediatr 1992, 120:360–366.
  Article PubMed CAS Google Scholar
• Akpede GO, Airede AI: Acute encephalopathy, hypertension and gram negative sepsis in sickle cell disease. West Afr J Med 1993, 12:180–184.
  PubMed CAS Google Scholar
• Pegelow CH, Macklin EA, Moser FG, et al.: Longitudinal changes in brain magnetic resonance imaging findings in children with sickle cell disease. Blood 2002, 99:3014–3018.
  Article PubMed CAS Google Scholar
• Bernaudin F, Verlhac S, Freard F, et al.: Multicenter prospective study of children with sickle cell disease: radiographic and psychometric correlation. J Child Neurol 2000, 15:333–343.
  Article PubMed CAS Google Scholar
• Saunders DE, Bynevelt M, Hewes DKM, et al.: MRI in children with sickle cell disease without overt stroke. Dev Med Child Neurol 2001, 43(Suppl 90):27.
  Google Scholar
• Glauser TA, Siegel MJ, Lee BC, DeBaun MR: Accuracy of neurologic examination and history in detecting evidence of MRI-diagnosed cerebral infarctions in children with sickle cell hemoglobinopathy. J Child Neurol 1995, 10:88–92.
  PubMed CAS Google Scholar
• Kinney TR, Sleeper LA, Wang WC: Silent cerebral infarcts in sickle cell anemia: a risk factor analysis. Pediatrics 1999, 103:640–645.
  Article PubMed CAS Google Scholar
• Powars DR, Wong WY, Vachon LA: Incomplete cerebral infarctions are not silent. J Pediatr Hematol Oncol 2001, 23:79–83.
  Article PubMed CAS Google Scholar
• Armstrong FD, Thompson RJ, Wang W, et al.: Cognitive functioning and brain magnetic resonance imaging in children with sickle cell disease. Pediatrics 1996, 97:864–870.
  PubMed CAS Google Scholar
• DeBaun MR, Schatz J, Siegel MJ, et al.: Cognitive screening examinations for silent cerebral infarcts in sickle cell disease. Neurology 1998, 50:1678–1682.
  PubMed CAS Google Scholar
• Watkins KE, Hewes DKM, Connelly A, et al.: Cognitive deficits associated with frontal lobe infarction in children with sickle cell disease. Dev Med Child Neurol 1998, 40:536–543.
  Article PubMed CAS Google Scholar
• Wang W, Enos L, Gallagher D, et al.: Cooperative Study of Sickle Cell Disease. Neuropsychologic performance in school-aged children with sickle cell disease: a report from the Cooperative Study of Sickle Cell Disease. J Pediatr 2001, 139:391–397.
  Article PubMed CAS Google Scholar
• Connelly A, Chong WK, Johnson CL, et al.: Diffusion weighted magnetic resonance imaging of compromised tissue in stroke. Arch Dis Child 1997, 77:38–41.
  PubMed CAS Google Scholar
• Pavlakis SG, Bello J, Prohovnik I, et al.: Brain infarction in sickle cell anemia: magnetic resonance imaging correlates. Ann Neurol 1988, 23:125–130.
  Article PubMed CAS Google Scholar
• Adams RJ, Nichols FT, McKie V, et al.: Cerebral infarction in sickle cell anemia: mechanism based on CT and MRI. Neurology 1988, 38:1012–1017.
  PubMed CAS Google Scholar
• Sébire G, Tabarki B, Saunders DE, et al.: Venous sinus thrombosis in children. Eur J Paediatr Neurol 2003, 7:263.
  Article Google Scholar
• Preul MC, Cendes F, Just N, Mohr G: Intracranial aneurysms and sickle cell anemia: multiplicity and propensity for the vertebrobasilar territory. Neurosurgery 1998, 42:971–977.
  Article PubMed CAS Google Scholar
• Stockman JA, Nigro MA, Mishkin MM, et al.: Occlusion of the large cerebral vessels in sickle cell anemia. N Engl J Med 1972, 287:846–849.
  Article PubMed CAS Google Scholar
• Wiznitzer M, Ruggieri PM, Masaryk TJ, et al.: Diagnosis of cerebrovascular disease in sickle cell anemia by magnetic resonance angiography. J Pediatr 1990, 117:551–555.
  Article PubMed CAS Google Scholar
• Kandeel AY, Zimmerman RA, Ohene-Frempong K: Comparison of magnetic resonance angiography and conventional angiography in sickle cell disease: clinical significance and reliability. Neuroradiology 1996, 38:409–416.
  Article PubMed CAS Google Scholar
• Gillams AR, McMahon L, Weinberg G, Carter AP: MRA of the intracranial circulation in asymptomatic patients with sickle cell disease. Pediatr Radiol 1998, 28:283–287.
  Article PubMed CAS Google Scholar
• Abboud MR, Cure J, Granger S, et al.: Magnetic resonance angiography in children with sickle cell disease and abnormal transcranial Doppler ultrasonography findings enrolled in the STOP study. Blood 2004, 103:2822–2826.
  Article PubMed CAS Google Scholar
• Dobson SR, Holden KR, Nietert PJ, et al.: Moyamoya syndrome in childhood sickle cell disease: a predictive factor for recurrent cerebrovascular events. Blood 2002, 99:3144–3150. Of 43 patients who had regular transfusions to maintain hemoglobin S of less than 30% for a mean of 6.6 years, 18 (44%) had recurrent stroke or transient ischemic attacks. Patients with moyamoya collaterals on angiography were more likely to have a recurrent event (58%) than those without.
  Article PubMed CAS Google Scholar
• Miller ST, Sleeper LA, Pegelow CH, et al.: Prediction of adverse outcomes in children with sickle cell disease. N Engl J Med 2000, 342:83–89.
  Article PubMed CAS Google Scholar
• Powars DR, Weiss JN, Chan LS, Schroeder WA: Is there a threshold level of fetal hemoglobin that ameliorates morbidity in sickle cell anemia? Blood 1984, 63:921–926.
  PubMed CAS Google Scholar
• Adekile AD, Yacoub F, Gupta R, et al.: Silent brain infarcts are rare in Kuwaiti children with sickle cell disease and high HbF. Am J Hematol 2002, 70:228–231.
  Article PubMed CAS Google Scholar
• Marouf R, Gupta R, Haider MZ, Adekile AD: Silent brain infarcts in adult Kuwaiti sickle cell disease patients. Am J Haematol 2003, 73:240–243.
  Article CAS Google Scholar
• Ware RE, Zimmerman SA, Schultz WH: Hydroxyurea as an alternative to blood transfusions for the prevention of recurrent stroke in children with sickle cell disease. Blood 1999, 94:3022–3026.
  PubMed CAS Google Scholar
• Wilkey O, Evans JPM, Telfer PT, Kirkham FJ: Predictors of nocturnal hypoxaemia in children with sickle cell disease. Arch Dis Child 2002; 86(Suppl 1):A12.
  Google Scholar
• Yamaja Setty BN, Stuart MJ, Dampier C, et al.: Hypoxemia in sickle cell disease: biomarker modulation and relevance to disease pathophysiology. Lancet 2003, 362:1450–1455.
  Article CAS Google Scholar
• Robertson PL, Aldrich MS, Hanash SM, Goldstein GW: Stroke associated with obstructive sleep apnea in a child with sickle cell anemia. Ann Neurol 1988, 23:614–616.
  Article PubMed CAS Google Scholar
• Davies SC, Stebbens VA, Samuels MP, Southall DP: Upper airways obstruction and cerebrovascular accident in children with sickle cell anaemia. Lancet 1989, 2:283–284.
  Article PubMed CAS Google Scholar
• Wilkey O, Chakravorty S, Mills W, et al.: Survival and complications in a cohort of neonatally screened children with sickle cell disease in East London. Br J Haem 2003, 121(Suppl 1):41.
  Google Scholar
• Pegelow CH, Colangelo L, Steinberg M, et al.: Natural history of blood pressure in sickle cell disease: risks for stroke and death associated with relative hypertension in sickle cell anemia. Am J Med 1997, 102:171–177.
  Article PubMed CAS Google Scholar
• Zafeiriou DI, Prengler M, Gombakis N, et al.: Central nervous system abnormalities in asymptomatic young patients with S beta-thalassemia. Ann Neurol 2004, 55:835–839.
  Article PubMed Google Scholar
• Knight S, Singhal A, Thomas P, Serjeant G: Factors associated with lowered intelligence in homozygous sickle cell disease. Arch Dis Child 1995, 73:316–320.
  PubMed CAS Google Scholar
• Kirkham FJ, Hogan A, Watkins KE, et al.: Risk factors for cognitive problems in sickle cell disease. Dev Med Child Neurol 2000, 42(Suppl 85):48.
  Google Scholar
• van der Dijs FP, Schnog JJ, Brouwer DA, et al.: Elevated homocysteine levels indicate suboptimal folate status in pediatric sickle cell patients. Am J Hematol 1998, 59:192–198.
  Article PubMed Google Scholar
• van der Dijs FP, Fokkema MR, Dijck-Brouwer DA, et al.: Optimization of folic acid, vitamin B(12), and vitamin B(6) supplements in pediatric patients with sickle cell disease. Am J Hematol 2002, 69:239–246.
  Article PubMed CAS Google Scholar
• Houston PE, Rana S, Sekhsaria S, et al.: Homocysteine in sickle cell disease: relationship to stroke. Am J Med 1997, 103:192–196.
  Article PubMed CAS Google Scholar
• Rodriguez-Cortes HM, Griener JC, Hyland K, et al.: Plasma homocysteine levels and folate status in children with sickle cell anemia. J Pediatr Hematol Oncol 1999, 21:219–223.
  Article PubMed CAS Google Scholar
• Balasa VV, Gruppo RA, Gartside PS, Kalinyak KA: Correlation of the C677T MTHFR genotype with homocysteine levels in children with sickle cell disease. J Pediatr Hematol Oncol 1999, 21:397–400.
  Article PubMed CAS Google Scholar
• Balasa VV, Kalinyak KA, Bean JA, et al.: Hyperhomocysteinemia is associated with low plasma pyridoxine levels in children with sickle cell disease. J Pediatr Hematol Oncol 2002, 24:374–379.
  Article PubMed Google Scholar
• Lowenthal EA, Mayo MS, Cornwell PE, Thornley-Brown D: Homocysteine elevation in sickle cell disease. J Am Coll Nutr 2000, 19:608–612.
  PubMed CAS Google Scholar
• Nelson MC, Zemel BS, Kawchak DA, et al.: Vitamin B6 status of children with sickle cell disease. J Pediatr Hematol Oncol 2002, 24:463–469.
  Article PubMed Google Scholar
• Dhar M, Bellevue R, Carmel R: Pernicious anemia with neuropsychiatric dysfunction in a patient with sickle cell anemia treated with folate supplementation. N Engl J Med 2003, 348:2204–2207.
  Article PubMed Google Scholar
• Dhar M, Bellevue R, Brar S, Carmel R: Mild hyperhomocysteinemia in adult patients with sickle cell disease: a common finding unrelated to folate and cobalamin status. Am J Hematol 2004, 76:114–120.
  Article PubMed CAS Google Scholar
• Morris CR, Kuypers FA, Larkin S, et al.: Patterns of arginine and nitric oxide in patients with sickle cell disease with vaso-occlusive crisis and acute chest syndrome. J Pediatr Hematol Oncol 2000, 22:515–520.
  Article PubMed CAS Google Scholar
• Morris CR, Morris SM Jr, Hagar W, et al.: Arginine therapy: a new treatment for pulmonary hypertension in sickle cell disease? Am J Respir Crit Care Med 2003, 168:63–69.
  Article PubMed Google Scholar
• Jaja SI, Ikotun AR, Gbenebitse S, Temiye EO: Blood pressure, hematologic and erythrocyte fragility changes in children suffering from sickle cell anemia following ascorbic acid supplementation. J Trop Pediatr 2002, 48:366–370.
  Article PubMed CAS Google Scholar
• Ohnishi ST, Ohnishi T, Ogunmola GB: Sickle cell anemia: a potential nutritional approach for a molecular disease. Nutrition 2000, 16:330–338.
  Article PubMed CAS Google Scholar
• Sarnaik S, Soorya D, Kim J, Ravindranath YJL: Periodic transfusions for sickle cell anemia and CNS infarction. Am J Dis Child 1979, 133:1254–1257.
  PubMed CAS Google Scholar
• Millman G, Thompson D, Kirkham FJ: Surgical decompression for malignant middle cerebral artery territory infarction in childhood. Dev Med Child Neurol 1998, 40(Suppl 79):24.
  Google Scholar
• Portnoy BA, Herion JC: Neurological manifestations in sickle-cell disease, with a review of the literature and emphasis on the prevalence of hemiplegia. Ann Intern Med 1972, 76:643–652.
  PubMed CAS Google Scholar
• Powars D, Wilson B, Imbus C, Pegelow C, Allen J: The natural history of stroke in sickle cell disease. Am J Med 1978, 65:461–471.
  Article PubMed CAS Google Scholar
• Wood DH: Cerebrovascular complications of sickle cell anemia. Stroke 1978, 9:73–75.
  PubMed CAS Google Scholar
• Wilimas J, Goff JR, Anderson HR Jr, et al.: Efficacy of transfusion therapy for one to two years in patients with sickle cell disease and cerebrovascular accidents. J Pediatr 1980, 96:205–208.
  Article PubMed CAS Google Scholar
• Moohr JW, Wilson H, Pang EJ: Strokes and their management in sickle cell disease. In Comparitive Clinical Aspects of Sickle Cell Disease. Edited by Fried W. Amsterdam: Elsevier; 1982:101–111.
  Google Scholar
• Russell MO, Goldberg HI, Hodson A, et al.: Effect of transfusion therapy on arteriographic abnormalities and on recurrence of stroke in sickle cell disease. Blood 1984, 63:162–169.
  PubMed CAS Google Scholar
• Wang WC, Kovnar EH, Tonkin IL, et al.: High risk of recurrent stroke after discontinuance of five to twelve years of transfusion therapy in patients with sickle cell disease. J Pediatr 1991, 118:377–382.
  Article PubMed CAS Google Scholar
• Cohen AR, Martin MB, Silber JH, et al.: A modified transfusion program for prevention of stroke in sickle cell disease. Blood 1992, 79:1657–1661.
  PubMed CAS Google Scholar
• Rana S, Houston PE, Surana N, et al.: Discontinuation of long-term transfusion therapy in patients with sickle cell disease and stroke. J Pediatr 1997, 131:757–760.
  Article PubMed CAS Google Scholar
• Pegelow CH, Adams RJ, McKie V, et al.: Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions. J Pediatr 1995, 126:896–899.
  Article PubMed CAS Google Scholar
• Prengler M, Ganesan V, Dick M, et al.: Risk factors for recurrent transient ischaemic event and stroke in sickle cell disease. Dev Med Child Neurol 2001, 43(Suppl 90):27.
  Google Scholar
• Sumoza A, de Bisotti R, Sumoza D, Fairbanks V: Hydroxyurea (HU) for prevention of recurrent stroke in sickle cell anemia (SCA). Am J Hematol 2002, 71:161–165.
  Article PubMed CAS Google Scholar
• Vernet O, Montes JL, O’Gorman AM, et al.: Encephaloduroarterio-synangiosis in a child with sickle cell anemia and moyamoya disease. Pediatr Neurol 1996, 14:226–230.
  Article PubMed CAS Google Scholar
• Mendelowitsch A, Sekhar LN, Clemente R, Shuaib A: EC-IC bypass improves chronic ischemia in a patient with moyamoya disease secondary to sickle cell disease: an in vivo microdialysis study. Neurol Res 1997, 19:66–70.
  PubMed CAS Google Scholar
• Schmugge M, Frischknecht H, Yonekawa Y, et al.: Stroke in hemoglobin (SD) sickle cell disease with moyamoya: successful hydroxyurea treatment after cerebrovascular bypass surgery. Blood 2001, 97:2165–2167.
  Article PubMed CAS Google Scholar
• Fryer RH, Anderson RC, Chiriboga CA, Feldstein NA: Sickle cell anemia with moyamoya disease: outcomes after EDAS procedure. Pediatr Neurol 2003, 29:124–130. Of six patients who had encephalodurosynarterioangiosis for moyamoya with sickle cell disease, one had a stroke 2 weeks after surgery, but the other patients were free of additional events for a mean follow-up period of 33 months.
  Article PubMed Google Scholar
• Hogan A, Watkins K, Kirkham F, Neville B, et al.: The importance of longitudinal cognitive evaluation in the clinical management of children with moyamoya disease. Dev Med Child Neurol 1998, 40(Suppl 79):8.
  Google Scholar
• Vermylen C, Cornu G, Ferster A, et al.: Haematopoietic stem cell transplantation for sickle cell anaemia: the first 50 patients transplanted in Belgium. Bone Marrow Transplant 1998, 22:1–6.
  Article PubMed CAS Google Scholar
• Bernaudin F: Results and current indications of bone marrow allograft in sickle cell disease. Pathol Biol (Paris) 1999, 47:59–64.
  CAS Google Scholar
• Walters MC, Storb R, Patience M, et al.: Impact of bone marrow transplantation for symptomatic sickle cell disease: an interim report. Multicenter investigation of bone marrow transplantation for sickle cell disease. Blood 2000, 95:1918–1924. This multicenter study found that Kaplan-Meier survival and disease-free-survival in 50 patients with sickle cell disease having bone marrow transplantation from HLA-compatible siblings were 94% and 84%, respectively. CNS disease stabilized clinically and radiologically in the 10 patients who had transplant because of stroke.
  PubMed CAS Google Scholar
• Adams RJ, Nichols FT, Figueroa R, et al.: Transcranial Doppler correlation with cerebral angiography in sickle cell disease. Stroke 1992, 23:1073–1077.
  PubMed CAS Google Scholar
• Nietert PJ, Abboud MR, Silverstein MD, Jackson SM: Bone marrow transplantation versus periodic prophylactic blood transfusion in sickle cell patients at high risk of ischemic stroke: a decision analysis. Blood 2000, 95(10):3057–3064.
  PubMed CAS Google Scholar
• Miller ST, Macklin EA, Pegelow CH, et al.: Silent infarction as a risk factor for overt stroke in children with sickle cell anemia: a report from the Cooperative Study of Sickle Cell Disease. J Pediatr 2001, 39:385–390.
  Google Scholar
• Hurlet-Jensen AM, Prohovnik I, Pavlakis SG, Piomelli S: Effects of total hemoglobin and hemoglobin S concentration on cerebral blood flow during transfusion therapy to prevent stroke in sickle cell disease. Stroke 1994, 25:1688–1692.
  PubMed CAS Google Scholar
• Brass LM, Prohovnik I, Pavlakis SG, et al.: Middle cerebral artery blood velocity and cerebral blood flow in sickle cell disease. Stroke 1991, 1:27–30.
  Google Scholar
• Royal JE, Seeler RA: Hypertension, convulsions and cerebral hemorrhage in sickle-cell anemia patients after blood transfusions. Lancet 1978, 2:1207.
  Article PubMed CAS Google Scholar
• Schmalzer EA, Lee JO, Brown AK, et al.: Viscosity of mixtures of sickle and normal red cells at varying hematocrit levels. Implications for transfusion. Transfusion 1987, 27:228–233.
  Article PubMed CAS Google Scholar
• Jan K, Usami S, Smith JA: Effects of transfusion on rheological properties of blood in sickle cell anemia. Transfusion 1982, 22:17–20.
  Article PubMed CAS Google Scholar
• Hassell KL, Eckman JR, Lane PA: Acute multiorgan failure syndrome: a potentially catastrophic complication of severe sickle cell pain episodes. Am J Med 1994, 96:155–162.
  Article PubMed CAS Google Scholar
• Charache S, Bleecker ER, Bross D: Effects of blood transfusion on exercise capacity in patients with sickle cell anemia. Am J Med 1983, 74:757–764.
  Article PubMed CAS Google Scholar
• Brown MM, Marshall J: Regulation of cerebral blood flow in response to changes in blood viscosity. Lancet 1985, 1:604–609.
  Article PubMed CAS Google Scholar
• Danielson CF: The role of red blood cell exchange transfusion in the treatment and prevention of complications of sickle cell disease. Ther Apher 2002, 6:24–31.
  Article PubMed Google Scholar
• Stam J, de Bruijn S, deVeber G: Anticoagulation for cerebral sinus thrombosis. Stroke 2003, 34:1054–1055. This systematic review of the available evidence suggested that there was an argument for anticoagulation with intravenous or low molecular weight heparin in adults and children with proven sinovenous thrombosis
  Article PubMed Google Scholar
• McQuaker IG, Jaspan T, McConachie NS, Dolan G: Coil embolization of cerebral aneurysms in patients with sickling disorders. Br J Haematol 1999, 106:388–390.
  Article PubMed CAS Google Scholar
• Cheatham ML, Brackett CE: Problems in management of sub-arachnoid hemorrhage in sickle cell anemia. J Neurosurg 1965, 23:488–493
  Article PubMed CAS Google Scholar